Using Machine Learning to Identify Bone Marrow Microenvironments in MDS, AML
The bone marrow microenvironment (BME) of myelodysplastic syndromes (MDS) is very different from the BME of acute myeloid leukemia (AML), and both are different from the BME of bone marrow without mutations, according to a study presented at the 2023 American Society of Clinical Oncology Annual Meeting. Investigators, led by Maher Albitar, extracted RNA from fresh bone marrow samples of 626 patients with AML, 564 patients with MDS, and more than 1400 patients whose bone marrow was without any mutations (considered normal). Subsequently, the RNA levels of 42 immune biomarkers were assessed using next-generation sequencing. The researchers used a ...
Advertisement
Advertisement
Advertisement

DocWire Content Partners

Expert Interviews

Network Websites